Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

ETFs To Gain On China's Upbeat Exports Data For December

Published 01/15/2020, 06:07 AM
Updated 07/09/2023, 06:31 AM
UK100
-
FXI
-

China’s export and import data for December 2019 looks encouraging. In dollar-terms, China’s exports climbed 7.6% in December comparing favorably with the 1.3% decline in November. Meanwhile, imports rose 16.3% in December against a rise of 0.3% in November. Both the metrics beat analysts’ expectations of a year-over-year increase in exports of 3.2% and imports of 9.6% in the same period, per a Reuters’ poll. Notably, trade surplus in December came in at $46.79 billion in comparison to analyst expectation of $48 billion.

However, for 2019, China’s export levels fell 0.5% in U.S. dollar terms as against an increase of 9.9% in 2018. Moreover, imports saw a decline of 2.8% in 2019 in dollar terms (read: After a Solid 2019, 5 China ETFs to Keep Rallying in 2020).

What’s Behind the Numbers?

Trade war with United States has been challenging China’s economic growth. Trade tussles led to a 10.7% decline in the trade value with the United States in 2019. It also reduced United States to being China’s third-largest trading partner, with European Union and the ASEAN region taking the top spots.

Moreover, a subdued domestic demand is still impacting China’s import numbers.

Sino-US Trade Relationship Status

China and United States are prepared to seal the phase one of trade deal on January 15, 2020. It is worth noting here that the nations have started to take the promised steps. The December 2019 import numbers for China reflect increasedpurchases, especially of soybean and pork from the United States. Meanwhile, on Jan 13, 2020, the US treasury Department announced the removal of China from a list of countries labelled as currency manipulators.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

It is being believed that the phase-one trade deal will help improve trade conditions around the globe but the relief will be temporary. China will have to grapple with 25% tariffs on $250 billion worth of Chinese industrial goods and components that are used by manufacturers in the United States. The tariff-related issues are expected to be dealt with in the phase two of the trade deal.

ETFs in Focus

Against this backdrop, investors can keep a tab on a few China ETFs like iShares China Large-Cap ETF (TE:FXI) , iShares MSCI China ETF MCHI, Xtrackers Harvest CSI 300 China A-Shares ETF ASHR and Invesco Golden Dragon China ETF PGJ.

FXI

This fund seeks long-term growth by tracking the investment returns, before fees and expenses, of the FTSE China 50 Index. It comprises 50 holdings. The fund’s AUM is $4.77 billion and expense ratio is 0.74%.

MCHI

This fund tracks the MSCI China Index. It comprises 597 holdings. The fund’s AUM is $4.99 billion and expense ratio is 0.59% (read: ETF Winners as US-China Deal Eases Trade Tensions).

ASHR

This fund tracks the CSI 300 Index. It comprises 302 holdings. The fund’s AUM is $2.41 billion and expense ratio is 0.65% (read: Should You Buy China ETFs Now?).

PGJ

This fund follows the NASDAQ Golden Dragon China Index, which offers exposure to the U.S. exchange-listed companies that are headquartered or incorporated in the People’s Republic of China. It holds a basket of 66 stocks. The product has AUM of $213.7 million and charges 70 bps in annual fees.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>



iShares MSCI China ETF (MCHI): ETF Research Reports

Invesco Golden Dragon China ETF (PGJ): ETF Research Reports

Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR): ETF Research Reports

iShares China Large-Cap ETF (FXI): ETF Research Reports

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.